Vita Life Sciences Limited (ASX:VLS)

Australia · Delayed Price · Currency is AUD

2.500

+0.050 (2.04%)

Jun 19, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Vms Investment - China & Vietnam	7.93M	8.94M	-	-	-
Vms Investment - China & Vietnam Growth	-11.26%	-	-	-	-
Vms Operational - Malaysia & Singapore	44.81M	33.23M	-	-	-
Vms Operational - Malaysia & Singapore Growth	34.82%	-	-	-	-
Vms Operational - Australia	40.53M	37.34M	-	-	-
Vms Operational - Australia Growth	8.57%	-	-	-	-
Total	93.27M	79.51M	-	-	-
Total Growth	17.31%	-	-	-	-

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Singapore	6.25M	5.83M	5.58M
Singapore Growth	7.33%	4.33%	14.31%
Malaysia	22.83M	21.39M	19.19M
Malaysia Growth	6.71%	11.48%	13.79%
Australia	42.76M	37.33M	30.30M
Australia Growth	14.53%	23.22%	45.80%
Others	1.59M	2.34M	2.03M
Others Growth	-31.92%	14.95%	-48.58%
Total	73.43M	66.89M	57.10M
Total Growth	9.78%	17.14%	22.85%